Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study.

Journal of Computer-aided Molecular Design
Mariangela AgamennoneRoberto Paciotti

Abstract

A multilayered computational workflow was designed to identify a druggable binding site on the surface of the E200K pathogenic mutant of the human prion protein, and to investigate the effect of the binding of small molecules in the inhibition of the early aggregation of this protein. At this purpose, we developed an efficient computational tool to scan the molecular interaction properties of a whole MD trajectory, thus leading to the characterization of plausible binding regions on the surface of PrP-E200K. These structural data were then employed to drive structure-based virtual screening and fragment-based approaches to the seeking of small molecular binders of the PrP-E200K. Six promising compounds were identified, and their binding stabilities were assessed by MD simulations. Therefore, analyses of the molecular electrostatic potential similarity between the bound complexes and unbound protein evidenced their potential activity as charged-based inhibitors of the PrP-E200K early aggregation.

References

Aug 1, 1992·Journal of Neurochemistry·B Caughey, R E Race
Mar 1, 1992·The Journal of General Virology·A LadoganaM Pocchiari
Aug 27, 1981·Biochimica Et Biophysica Acta·A Y WoodyR W Woody
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·K KanekoS B Prusiner
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·S B Prusiner
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·R ZahnK Wüthrich
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·C KorthS B Prusiner
Apr 15, 2003·Journal of Virology·Byron CaugheyGerald S Baron
Jun 17, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Chongsuk RyouStanley B Prusiner
Aug 12, 2003·Nature Biotechnology·Stéphane BachMarc Blondel
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Jan 6, 2005·The Journal of Biological Chemistry·Eric A GreenbaumBenoit I Giasson
Oct 8, 2005·Journal of Computational Chemistry·David Van Der SpoelHerman J C Berendsen
Dec 28, 2005·Journal of Virology·David A Kocisko, Byron Caughey
Jan 20, 2006·Journal of Medicinal Chemistry·Tummala R K ReddyBeining Chen
Feb 7, 2006·Journal of Molecular Graphics & Modelling·Junmei WangDavid A Case
Jun 8, 2006·Annual Review of Biochemistry·Fabrizio Chiti, Christopher M Dobson
Mar 27, 2007·Chemical Biology & Drug Design·Tom Halgren
May 4, 2007·European Journal of Medicinal Chemistry·Kai GuoBeining Chen
Jul 10, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kazuo KuwataShigeru Katamine
Jan 17, 2008·The Journal of General Virology·Constanze RiemerMichael Baier
Aug 19, 2011·The FEBS Journal·Rolando Perez-PineiroDavid S Wishart
Jul 25, 2012·BMC Research Notes·Alan W Sousa da Silva, Wim F Vranken
Nov 8, 2012·The Journal of Biological Chemistry·Cleiton F MachadoVilma R Martins
Apr 25, 2013·Journal of the American Chemical Society·Fernando L PalhanoJeffery W Kelly
Jul 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Brandon B HolmesMarc I Diamond
Jan 1, 2014·Structure·Pravas Kumar BaralMichael N G James
Feb 12, 2015·Journal of the American Chemical Society·Danzhi Huang, Amedeo Caflisch
Sep 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Stanley B PrusinerKurt Giles
Oct 20, 2015·Journal of Chemical Information and Modeling·Teague Sterling, John J Irwin
Apr 26, 2016·Accounts of Chemical Research·Antonia StankRebecca C Wade
Jun 23, 2016·EBioMedicine·Daisuke IshibashiNoriyuki Nishida

❮ Previous
Next ❯

Software Mentioned

VMD
gromos
OPLS
Knime
Antechamber
Canvas
MacroModel
FingerPrintGen
Maestro
Python

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.